28122459|t|Increased dissolution rates of tranilast solid dispersions extruded with inorganic excipients
28122459|a|The purpose of this study was to evaluate the performance of Neusilin ® (NEU) a synthetic magnesium aluminometasilicate as an inorganic drug carrier co-processed with the hydrophilic surfactants Labrasol and Labrafil to develop Tranilast (TLT)-based solid dispersions using continuous melt extrusion (HME) processing. Twin-screw extrusion was optimized to develop various TLT / excipient / surfactant formulations followed by continuous capsule filling in the absence of any downstream equipment. Physicochemical characterization showed the existence of TLT in partially crystalline state in the porous network of inorganic NEU for all extruded formulations. Furthermore, in-line NIR studies revealed a possible intermolecular H-bonding formation between the drug and the carrier resulting in the increase of TLT dissolution rates. The capsules containing TLT -extruded solid dispersions showed enhanced dissolution rates and compared with the marketed Rizaben (®) product.
28122459	10	21	dissolution	T058	UMLS:C1285147
28122459	41	58	solid dispersions	T103	UMLS:C3859614
28122459	83	93	excipients	T103	UMLS:C0015237
28122459	155	163	Neusilin	T103	UMLS:C3714234
28122459	167	170	NEU	T103	UMLS:C3714234
28122459	184	213	magnesium aluminometasilicate	T103	UMLS:C0051515
28122459	230	242	drug carrier	T103	UMLS:C0013161
28122459	277	288	surfactants	T103	UMLS:C0038891
28122459	289	297	Labrasol	T103	UMLS:C1099415
28122459	302	310	Labrafil	T103	UMLS:C0038891
28122459	322	331	Tranilast	T103	UMLS:C0146337
28122459	333	336	TLT	T103	UMLS:C0146337
28122459	344	361	solid dispersions	T103	UMLS:C3859614
28122459	466	469	TLT	T103	UMLS:C0146337
28122459	472	481	excipient	T103	UMLS:C0015237
28122459	484	494	surfactant	T103	UMLS:C0038891
28122459	531	538	capsule	T103	UMLS:C0006935
28122459	539	546	filling	T058	UMLS:C3830127
28122459	648	651	TLT	T103	UMLS:C0146337
28122459	665	682	crystalline state	T103	UMLS:C0444626
28122459	708	721	inorganic NEU	T103	UMLS:C3714234
28122459	766	785	in-line NIR studies	T058	UMLS:C0376519
28122459	853	857	drug	T103	UMLS:C1254351
28122459	866	873	carrier	T103	UMLS:C0013161
28122459	903	906	TLT	T103	UMLS:C0146337
28122459	907	918	dissolution	T058	UMLS:C1285147
28122459	930	938	capsules	T103	UMLS:C0006935
28122459	950	953	TLT	T103	UMLS:C0146337
28122459	964	981	solid dispersions	T103	UMLS:C3859614
28122459	998	1009	dissolution	T058	UMLS:C1285147
28122459	1047	1054	Rizaben	T103	UMLS:C0282555